Hernan F Guillen-Burgos

Dr. Hernan F Guillen-Burgos

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 September 2023 in General Hospital Psychiatry
Verified
Journal Article
Open access
HGHernan F Guillen-Burgos
Hernan F Guillen-Burgos
JGJuan Francisco Galvez-Florez
Juan Francisco Galvez-Florez
SMSergio Moreno-Lopez
Sergio Moreno-Lopez
IGIsabella Gonzalez
Isabella Gonzalez
MGManuela Guillen
Manuela Guillen
Juan-Manuel AnayaJuan-Manuel Anaya
Juan-Manuel Anaya
Investigate the proportion of mental health outcomes (MHOs) and associated factors in COVID-19 survivors during a 24-month follow-up period. An observational, prospective study was performed in a teaching hospital in Barranquilla, Colombia, from April 1, 2020, to August 30, 2022. A cohort of 1565 COVID-19 survivors was recruited after discharge from the emergency room (ER), inpatient floor (IF), and intensive care unit (ICU) services and followed for 24 -months. The clinical assessment included screening scales for symptoms of anxiety, depressive, post-traumatic stress disorder (PTSD), and insomnia. Sociodemographic and clinical factors were also collected to identify possible associated factors. Descriptive, bivariate and mixed random-effect linear models were performed. A total of 1565 patients were included, of whom 785 (50.35%) were men. A large proportion of patients with mental symptoms were identified. After 24-months, the proportions of anxiety, depression, PTSD, and insomnia symptoms remained high at 16.55%, 21.79%, 35.27%, and 23.86%, respectively. Social factors, location of hospital stays, physical comorbidities, and the severity of COVID-19 were significantly associated with anxiety, depression, PTSD, and insomnia symptoms. COVID-19's 2-year deleterious impacts on mental health, as well as the variables influencing these findings, have been documented. These results should aid in the development of public health initiatives to reduce morbidity rates in post-COVID-19 patients.

18 June 2024 in Journal of Affective Disorders
Verified
Journal Article
Closed access
DDDonovan A. Dev
Donovan A. Dev
GLGia Han Le
Gia Han Le
Angela Kwan, MD, MScAngela Kwan, MD, MSc
Angela Kwan, MD, MSc
SWSabrina Wong
Sabrina Wong
AAAkhilan Arulmozhi
Akhilan Arulmozhi
RMRoger McIntyre
Roger McIntyre

10 February 2023 in International Journal of Bipolar Disorders
Verified
Journal Article
Open access
PDF file
HGHernan F Guillen-Burgos
Hernan F Guillen-Burgos
SMSergio Moreno-Lopez
Sergio Moreno-Lopez
KAKaleb Acevedo-Vergara
Kaleb Acevedo-Vergara
MPManuel Pérez-Florez
Manuel Pérez-Florez
CPCatherine Pachón-Garcia
Catherine Pachón-Garcia
JGJuan Francisco Gálvez-Flórez
Juan Francisco Gálvez-Flórez
Background: Bipolar disorder (BD) is higher in developing countries. Childhood trauma exposure is a common environmental risk factor in Colombia and might be associated with a more severe course of bipolar disorder in Low-Middle Income-Countries. We carried out the first case–control study in Colombia using a structural clinical interview and the Childhood Trauma Questionnaire-Short Form (CTQ-SF) to describe the prevalence and association between trauma exposure during childhood with a severe course of illness (early age onset, rapid cycling, ideation or suicide attempt, or ≥ 3 hospitalization) in a sample of BD patients. Results: A total of 114 cases and 191 controls evaluated showed the following results. Cases included 61.4% BD type I and 38.6% BD type II. The median age was 31.5 years (IQR, 75–24) for BD patients and 31 years old (IQR, 38–24) for healthy controls. A higher prevalence of childhood trauma was evidenced in cases compared to controls. Emotional abuse, physical abuse, sexual abuse, physical neglect and emotional neglect evidenced a strong association with severe bipolar disorder (OR = 3.42, p < .001; OR = 4.68, p < .001; OR = 4.30, p = .003; OR = 5.10, p < .001; OR = 5.64, p < .001, respectively). Conclusions: This is the first association study between childhood trauma exposure as a higher risk for a severe course of illness in BD patients in Colombian. Our findings highlight the higher prevalence of childhood trauma in bipolar patients and the strong association of childhood trauma with severe bipolar disorder. These findings are relevant for screening and evaluating childhood trauma exposure during the course of BD patients.

28 November 2025 in Journal of Affective Disorders
Verified
Journal Article
Open access
SWSabrina Wong
Sabrina Wong
GLGia Han Le
Gia Han Le
HGHernan F Guillen-Burgos
Hernan F Guillen-Burgos
RHRoger C. Ho
Roger C. Ho
BCBing Cao
Bing Cao
RMRoger McIntyre
Roger McIntyre
Persons with depression are differentially affected by metabolic alterations, notably, insulin resistance and dyslipidemia. Metabolic alterations affect acute pharmacotherapy response and predispose risk for cardiovascular diseases. We aimed to extend knowledge pertaining to the depression-metabolic alteration association by evaluating whether depressive symptom severity moderates the association. We conducted a systematic search of PubMed, Ovid and Scopus from inception to May 2025. Two reviewers (S.W. and G.H.L.) independently screened the identified studies. Studies were included if they enrolled adults with depression and reported on at least one metabolic parameter (i.e., fasting glucose, insulin, lipid panels). Standardized mean differences of metabolic parameters were pooled across studies. We identified 28 studies for inclusion. Persons with depression exhibited higher fasting glucose (SMD = 0.30, 95 % CI [0.12, 0.48]) and dyslipidemia [i.e., trends of increased low-density lipoprotein (SMD = 0.21, 95 % CI [-0.03, 0.44]) and lower high-density lipoprotein (SMD = -0.72, 95 % CI [-1.41, -0.03])]. Measures of insulin resistance were positively associated with anhedonia severity, sleep disturbances, and suicidal ideation. Between-study methodological differences, including study design and sociodemographics, affects the synthesis of overall trends. Herein, we identify an association between depressive symptom severity and dysglycemia, dyslipidemia and insulin resistance. The results augment the conceptual framework implicating metabolic disturbances in depression pathophysiology and indirectly support testing that therapeutics currently in development in the treatment of depression (e.g., GLP-1 receptor agonists) may exhibit differential efficacy as a function of illness severity.

19 August 2022 in Journal of Affective Disorders Reports
Verified
Journal Article
Open access
HGHernan F Guillen-Burgos
Hernan F Guillen-Burgos
JGJanitza Gomez-Ureche
Janitza Gomez-Ureche
CRCarlos Renowitzky
Carlos Renowitzky
KAKaleb Acevedo-Vergara
Kaleb Acevedo-Vergara
MPManuel Perez-Florez
Manuel Perez-Florez
JGJuan Francisco Galvez-Florez
Juan Francisco Galvez-Florez
Mental health outcomes in Healthcare Workers (HCWs) has been few evaluated during COVID-19 pandemic in low-and middle-income countries. Our aim was carry-out a study to identify the prevalence of stress, anxiety, depressive symptoms in HCWs and associated factors to severe illness in a northern region in Colombia. A cross-sectional, hospital-based survey was conducted to assess mental health outcomes in 1,149 HCWs in Colombia. The study used Perceived Stress Scale (PSS-10), 7-item Generalized Anxiety Disorder (GAD-7), and 9-item Patient Health Questionnaire (PHQ-9) to evaluate stress, anxiety, and depression symptoms, respectively. 682 HCWs completed the questionnaire. The 58,21% (397/682) were nurses, 31,23% were physicians (213/682), and 10,56% (72/682) were other health professionals. The proportion of HCWs with stress, anxiety, and depressive symptoms were 59,97%, 44,87%, and 23,02%, respectively. HCWs in emergency room and Intensive Care Units (ICU) have 2-3-fold increase risk to have severe symptoms of stress. Staff in ICU have 64% more likely to have severe anxiety symptoms, and 97% more likely to have severe depression symptoms. Including HCWs only in the northern region in Colombia; a non-probabilistic sample, and a cross-sectional design to identify causality. A higher proportion on mental health outcomes has been reported in HCWs in Colombia. There are work areas related with severe mental symptoms such as ICU and emergency room. Hospitals and patient-care institutions in Latin-America needs consider the mental and physical health of HCWs during outbreaks and identify health staff at-risk to implementing support strategies to mitigate adverse mental outcomes.

23 March 2021 in BMC Neurology
Verified
Journal Article
Open access
PDF file
NMNuvia Mackenzie
Nuvia Mackenzie
ELEva Lopez-Coronel
Eva Lopez-Coronel
ADAlberto Dau
Alberto Dau
DMDieb Maloof
Dieb Maloof
SMSalvador Mattar
Salvador Mattar
HGHernan F Guillen-Burgos
Hernan F Guillen-Burgos
Background: During the Coronavirus disease 2019 (COVID-19) pandemic, different neurological manifestations have been observed. However, only a few cases of Guillain-Barre syndrome (GBS) and COVID-19 have been reported. Therefore, the aim of this study is to investigate a case of concomitant GBS with COVID-19 in Colombia. Case presentation: A 39-year-old woman was admitted to a teaching hospital in Barranquilla, Colombia with a history of progressive general weakness with lower limb dominance. Previous symptoms such as ageusia, anosmia and intense headache were reported. Upon admission, facial diplegia, quadriparesis with lower extremity predominance and Medical Research Council muscular strength of 2/5 in the lower limbs and 4/5 in the upper limbs were reported. During clinical evolution, due to general areflexia, hypertensive emergency and progressive diaphragmatic weakness, the patient was admitted to an intensive care unit. The cerebrospinal fluid analysis showed protein-cytological dissociation and the GBS diagnosis was confirmed via a nerve conduction and electromyography test. With regard to the symptoms before hospitalisation, SARS-CoV-2 diagnostic testing was performed with positive results in the second test. The patient was managed with supportive care and was discharged after 20 days of hospitalization with clinical improvement. Conclusions: Only a few cases of COVID-19 with GBS have been reported. Different subtypes have been previously identified, such as Miller-Fisher syndrome and dysautonomic GBS with SARS-CoV-2 infection. This study investigated the first confirmed case of COVID-19 with concomitant GBS in Colombia. In patients with GBS, several viral and bacterial pathogens have been found in case-control studies but the factors that induce the immune-mediated destruction of the nerve tissues have not been determined. Further studies are needed to determine the possible association between COVID-19 exposure and GBS.